» Articles » PMID: 24871369

Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2014 May 30
PMID 24871369
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) is a prevalent primary liver cancer that is derived from hepatocytes and is characterised by high mortality rate and poor prognosis. While HCC is driven by cumulative changes in the hepatocyte genome, it is increasingly recognised that the liver microenvironment plays a pivotal role in HCC propensity, progression and treatment response. The microenvironmental stimuli that have been recognised as being involved in HCC pathogenesis are diverse and include intrahepatic cell subpopulations, such as immune and stellate cells, pathogens, such as hepatitis viruses, and non-cellular factors, such as abnormal extracellular matrix (ECM) and tissue hypoxia. Recently, a number of novel environmental influences have been shown to have an equally dramatic, but previously unrecognized, role in HCC progression. Novel aspects, including diet, gastrointestinal tract (GIT) microflora and circulating microvesicles, are now being recognized as increasingly important in HCC pathogenesis. This review will outline aspects of the HCC microenvironment, including the potential role of GIT microflora and microvesicles, in providing new insights into tumourigenesis and identifying potential novel targets in the treatment of HCC.

Citing Articles

Fluorescence-guided Surgery for Hepatocellular Carcinoma: From Clinical Practice to Laboratories.

Xiao T, Chen D, Peng L, Li Z, Pan W, Dong Y J Clin Transl Hepatol. 2025; 13(3):216-232.

PMID: 40078203 PMC: 11894393. DOI: 10.14218/JCTH.2024.00375.


Impact of IL-8 on survival after TARE in HCC: a comprehensive investigation and external validation from the SORAMIC trial.

Schindler A, Fischer J, Beeskow A, Lincke T, Ebel S, Seehofer D J Cancer Res Clin Oncol. 2024; 150(11):486.

PMID: 39503874 PMC: 11541297. DOI: 10.1007/s00432-024-05947-4.


Novel Biomarkers for Early Detection of Hepatocellular Carcinoma.

Attia A, Rezaee-Zavareh M, Hwang S, Kim N, Adetyan H, Yalda T Diagnostics (Basel). 2024; 14(20).

PMID: 39451600 PMC: 11507329. DOI: 10.3390/diagnostics14202278.


Effect of Semaglutide on High-Fat-Diet-Induced Liver Cancer in Obese Mice.

Liu Y, Chen S, Zhen R J Proteome Res. 2024; 23(2):704-717.

PMID: 38227547 PMC: 10846501. DOI: 10.1021/acs.jproteome.3c00498.


Liver organoids and their application in liver cancer research.

Song X, Hou K, Zhou H, Yang J, Cao T, Zhang J Regen Ther. 2024; 25:128-137.

PMID: 38226058 PMC: 10788409. DOI: 10.1016/j.reth.2023.12.011.


References
1.
Schoniger-Hekele M, Muller C, Kutilek M, Oesterreicher C, Ferenci P, Gangl A . Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation. Eur J Gastroenterol Hepatol. 2000; 12(8):941-8. DOI: 10.1097/00042737-200012080-00015. View

2.
Villanueva A, Alsinet C, Yanger K, Hoshida Y, Zong Y, Toffanin S . Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice. Gastroenterology. 2012; 143(6):1660-1669.e7. PMC: 3505826. DOI: 10.1053/j.gastro.2012.09.002. View

3.
Lee H, Park M, Yang S, Park K, Kim N, Kim Y . Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells. Life Sci. 2006; 80(7):690-8. DOI: 10.1016/j.lfs.2006.10.024. View

4.
Jiang Y, Yang Z, Hu J . Recurrence or metastasis of HCC:predictors, early detection and experimental antiangiogenic therapy. World J Gastroenterol. 2002; 6(1):61-65. PMC: 4723599. DOI: 10.3748/wjg.v6.i1.61. View

5.
Beasley R . Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 1988; 61(10):1942-56. DOI: 10.1002/1097-0142(19880515)61:10<1942::aid-cncr2820611003>3.0.co;2-j. View